Status:
COMPLETED
Evaluation of End of Life Quality of Care
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Neoplasm Malignant
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
The study uses a mixed method study to evaluate wether the use of the indicators of the Quality of end-of-life cancer care, developed by Earle et al \[Earle JCO 2003; DOI: 10.1200/JCO.2003.03.059\] wo...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients aged ≥ 18,
- diagnosed with advanced cancer (recruited from hospital activity data, by a stay with a ICD code of metastatic cancer between Oct 1st, 2009 and Dec 31, 2010)
- deceased between, Jan 1st, 2010 and Dec 31, 2010 (vital status identified either from hospital activity data, or from national mortality statistics)
- Exclusion Criteria:
- diagnosis with non solid tumor (haematology)
- age \< 18
Exclusion
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2015
Estimated Enrollment :
997 Patients enrolled
Trial Details
Trial ID
NCT03775304
Start Date
January 1 2011
End Date
December 15 2015
Last Update
December 13 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
APHP Hôpital Cochin
Paris, France
2
APHP Hôpital Européen Georges Pompidou
Paris, France
3
APHP Hôpital Henri Mondor
Paris, France
4
Institut Gustave Roussy
Villejuif, France